Our Partners > Double Diamond Sponsor 2019


Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology.  The company is focused on the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102).  The Company also continues to deliver on its pipeline of differentiated investigational programs. For more information about Adamas and its unique approach to developing medicines based on time-dependent biology, please visit www.adamaspharma.com.


US WorldMeds is proud to be a Double Diamond Sponsor at this year’s Parkinson’s Unity Walk. US WorldMeds is committed to supporting patients and care partners to increase Parkinson’s disease awareness and help improve the quality of care. Stop by our tent to learn about our available PD treatment options, our Circle of Care™ Nurse Network and our Parkinson’s support initiatives.



Click for a printer friendly version